Discovery of 3,6-dihydro-2H-pyran as a morpholine replacement in 6-aryl-1H-pyrazolo[3,4-d]pyrimidines and 2-arylthieno[3,2-d]pyrimidines: ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR)

被引:49
作者
Kaplan, Joshua [1 ]
Verheijen, Jeroen C. [1 ]
Brooijmans, Natasja [1 ]
Toral-Barza, Lourdes [2 ]
Hollander, Irwin [2 ]
Yu, Ker [2 ]
Zask, Arie [1 ]
机构
[1] Wyeth Res, Chem Sci, Pearl River, NY 10965 USA
[2] Wyeth Res, Oncol Res, Pearl River, NY 10965 USA
关键词
SELECTIVE INHIBITORS; PATHWAY; CANCER; POTENT;
D O I
10.1016/j.bmcl.2009.11.050
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The morpholine hinge-region binding group on a series of pyrazolopyrimidine and thienopyrimidine mammalian target of rapamycin ( mTOR) inhibitors was replaced with 3,6-dihydro-2H-pyran (DHP), giving compounds of equivalent potency and selectivity versus PI3K. These results establish the DHP group as a hinge-region binding motif for the preparation of highly potent and selective mTOR inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:640 / 643
页数:4
相关论文
共 16 条
[1]   The PTEN-PI3K pathway: of feedbacks and cross-talks [J].
Carracedo, A. ;
Pandolfi, P. P. .
ONCOGENE, 2008, 27 (41) :5527-5541
[2]   Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation [J].
Choo, Andrew Y. ;
Yoon, Sang-Oh ;
Kim, Sang Gyun ;
Roux, Philippe P. ;
Blenis, John .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (45) :17414-17419
[3]  
Kiely J. S., 1990, U.S. Patent, Patent No. 4945160
[4]   Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase [J].
Nowak, Pawel ;
Cole, Derek C. ;
Brooijmans, Natasja ;
Bursavich, Matthew G. ;
Curran, Kevin J. ;
Ellingboe, John W. ;
Gibbons, James J. ;
Hollander, Irwin ;
Hu, YongBo ;
Kaplan, Joshua ;
Malwitz, David J. ;
Toral-Barza, Lourdes ;
Verheijen, Jeroen C. ;
Zask, Arie ;
Zhang, Wei-Guo ;
Yu, Ker .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (22) :7081-7089
[5]   Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex [J].
Sarbassov, DD ;
Guertin, DA ;
Ali, SM ;
Sabatini, DM .
SCIENCE, 2005, 307 (5712) :1098-1101
[6]  
*SCHR LLC, 2009, GEN CONFGEN VERS 2 1
[7]   Characterization of the cloned full-length and a truncated human target of rapamycin: Activity, specificity, and enzyme inhibition as studied by a high capacity assay [J].
Toral-Barza, L ;
Zhang, WG ;
Lamison, C ;
LaRocque, J ;
Gibbons, J ;
Yu, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (01) :304-310
[8]   Discovery of 4-(Benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(Pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as Potent and Selective Inhibitors of the Cyclin-Dependent Kinase 4 [J].
Tsou, Hwei-Ru ;
Liu, Xiaoxiang ;
Birnberg, Gary ;
Kaplan, Joshua ;
Otteng, Mercy ;
Tran, Tritin ;
Kutterer, Kristina ;
Tang, Zhilian ;
Suayan, Ron ;
Zask, Arie ;
Ravi, Malini ;
Bretz, Angela ;
Grillo, Mary ;
McGinnis, John P. ;
Rabindran, Sridhar K. ;
Ayral-Kaloustian, Semiramis ;
Mansour, Tarek S. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) :2289-2310
[9]   Discovery of 2-arylthieno[3,2-d]pyrimidines containing 8-oxa-3-azabicyclo[3.2.1]octane in the 4-position as potent inhibitors of mTOR with selectivity over PI3K [J].
Verheijen, Jeroen C. ;
Yu, Ker ;
Toral-Barza, Lourdes ;
Hollander, Irwin ;
Zask, Arie .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :375-379
[10]   Discovery of 4-Morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as Highly Potent and Selective ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 6-Aryl Substituent [J].
Verheijen, Jeroen C. ;
Richard, David J. ;
Curran, Kevin ;
Kaplan, Joshua ;
Lefever, Mark ;
Nowak, Pawel ;
Malwitz, David J. ;
Brooijmans, Natasja ;
Toral-Barza, Lourdes ;
Zhang, Wei-Guo ;
Lucas, Judy ;
Hollander, Irwin ;
Ayral-Kaloustian, Semiramis ;
Mansour, Tarek S. ;
Yu, Ker ;
Zask, Arie .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (24) :8010-8024